logo

Compass Therapeutics Inc (CMPX) Stock: The Story of a 52-Week Stock Range

ALXO Stock

A stock’s 52-week high and low prices can offer a wealth of information about its current standing and prospective future performance. Compass Therapeutics Inc’s current trading price is -57.46% away from its 52-week high, while its distance from the 52-week low is 33.91%. The stock’s price range for this time frame has been between $1.15 and $3.62. The trading volume of the company’s shares in the Healthcare reached around 0.68 million for the day, which was evidently higher than the average daily volume of 0.35 million over the last three months.

Compass Therapeutics Inc had a pretty Dodgy run when it comes to the market performance. Over the past year, the company’s stock reached a high of $3.62 on 05/23/23, while the lowest price during the same period was $1.15 on 02/05/24.

How Financial Performance Impacts Market Capitalization

Compass Therapeutics Inc (CMPX) has experienced a quarterly decline of -2.53% in its revenues when compared to the same period in the previous year. Presently, the company has a total market capitalization of 211.89M and boasts a workforce of 32 employees.

The Role of Moving Averages and Trading Volume in Technical Analysis

Based on Barchart.com data, the company’s moving average over the 100-day period was 1.6766, with a change in price of -0.0500. Similarly, Compass Therapeutics Inc recorded 453,491 in trading volume during the last 100 days, posting a change of -3.14%.

How CMPX’s Debt-to-Equity Ratio Affects Financial Health

A company’s financial condition and market reputation can be evaluated using the debt-to-equity (D/E) ratio. This ratio, calculated by dividing a company’s total liabilities by its shareholders’ equity, indicates the proportion of debt a company employs to back its assets in relation to its shareholders’ equity. At the time of writing, the total D/E ratio for CMPX stands at 0.01. Similarly, the long-term debt-to-equity ratio is also 0.00.

CMPX Stock Stochastic Average

The raw stochastic average for Compass Therapeutics Inc over the last 50 days is presently at 20.79%. This reflects a drop from the raw stochastic average of the previous 20 days, which was noted at 45.65%. Further, the company’s Stochastic %K and %D values for the last 20 days were 52.54% and 54.83%, respectively.

CMPX Stock Price Performance Analysis

The stock price performance for the year has been a mixed bag, indicating either a pessimistic or optimistic outlook depending on how you look at it. The index has shown a price loss of -1.28% this year. Over the last six months, there has been a weaker performance of 10.00%. The price of CMPX leaped by -1.91% during the last 30 days period. For the last 5-days stocks have slided -2.53%.

Most Popular